Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Language
Publication year range
1.
An Acad Bras Cienc ; 92(4): e20200519, 2020.
Article in English | MEDLINE | ID: mdl-33331446

ABSTRACT

Leiomyomas are the most common benign tumors in women. Many of them are associated with significant morbidity. The present study aimed to analyze histomorphological and histochemical characteristics and immunoexpression of Cripto-1 in oral leiomyomas (OL), uterine leiomyomas (UL), and normal myometrium (NM). Sample was composed of ten OL, 11 UL and 11 NM. Histomorphological characteristics were analyzed at 100 and 400x magnifications with HE staining. The immunoexpression of Cripto-1 was analyzed in five high-power fields. Statistical analysis considered a significant difference when p<0.05. Six OL disclosed moderate/intense inflammatory infiltrate, while ten UL exhibited mild infiltrate (p=0.024). When analyzing all leiomyomas together, 20 exhibited hyalinization, whereas no NM exhibited this alteration (p<0.001). There was no statistical difference in the distribution of mast cells among the lesions. The median Cripto-1 was higher in UL (9.0), followed by OL and NM (4.0). Associations of the Cripto-1 expression between leiomyomas (separately and together) and NM were statistically significant (p<0.001). These results indicate that OL and UL exhibit similar histomorphological and histochemical characteristics, as well as differences to NM. The higher immunoexpression of Cripto-1 in leiomyomas compared to NM suggests that this protein may influence cell proliferation and tissue architecture of oral and uterine leiomyomas.


Subject(s)
Leiomyoma , Uterine Neoplasms , Female , Humans , Myometrium
2.
J. bras. patol. med. lab ; J. bras. patol. med. lab;52(5): 349-353, Sept.-Oct. 2016. tab, graf
Article in English | LILACS | ID: biblio-829080

ABSTRACT

ABSTRACT Ameloblastic fibrosarcoma (AFS) is a rare malignant tumor characterized by benign epithelial component within a malignant fibrous stroma. It occurs as a de novo lesion or from a previous ameloblastic fibroma. The aim of this paper is to report an aggressive and recurrent case of AFS in the maxilla of a 38-year-old patient. Histopathological diagnosis can be challenging, especially when it is based on incisional biopsy specimens. Hence, this report highlights not only the importance of the histological features for diagnosis but also the clinical behavior of AFS based on current literature evidence.


RESUMO O fibrossarcoma ameloblástico (FSA) é um tumor maligno raro caracterizado pela presença de componente epitelial benigno em um tecido conjuntivo fibroso maligno. Pode desenvolver-se a partir de um fibroma ameloblástico ou como uma lesão nova. O objetivo deste estudo é relatar um caso de um FSA agressivo e recorrente em maxila em um paciente de 38 anos. O diagnóstico histopatológico desse tumor pode ser difícil, principalmente a partir de biópsias incisionais. Este trabalho também discute fatores em relação aos aspectos histopatológicos para o seu diagnóstico, assim como seu comportamento clínico, com base em revisão atual da literatura.

3.
Clin Sci (Lond) ; 130(10): 785-99, 2016 05 01.
Article in English | MEDLINE | ID: mdl-26823560

ABSTRACT

EEF1D (eukaryotic translation elongation factor 1δ) is a subunit of the elongation factor 1 complex of proteins that mediates the elongation process during protein synthesis via enzymatic delivery of aminoacyl-tRNAs to the ribosome. Although the functions of EEF1D in the translation process are recognized, EEF1D expression was found to be unbalanced in tumours. In the present study, we demonstrate the overexpression of EEF1D in OSCC (oral squamous cell carcinoma), and revealed that EEF1D and protein interaction partners promote the activation of cyclin D1 and vimentin proteins. EEF1D knockdown in OSCC reduced cell proliferation and induced EMT (epithelial-mesenchymal transition) phenotypes, including cell invasion. Taken together, these results define EEF1D as a critical inducer of OSCC proliferation and EMT.


Subject(s)
Carcinoma, Squamous Cell/genetics , Cell Proliferation/genetics , Epithelial-Mesenchymal Transition/genetics , Gene Expression Regulation, Neoplastic/genetics , Head and Neck Neoplasms/genetics , Mouth Neoplasms/genetics , Peptide Elongation Factor 1/genetics , Carcinoma, Squamous Cell/diagnosis , Cell Line, Tumor , Cell Movement/genetics , Head and Neck Neoplasms/diagnosis , Humans , Mouth Neoplasms/diagnosis , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Phenotype , Squamous Cell Carcinoma of Head and Neck
4.
Exp Mol Pathol ; 79(1): 79-85, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16005715

ABSTRACT

The purpose of this research was to evaluate the immunohistochemical expression of the vascular endothelial growth factor (VEGF-C1) and measuring the angiogenic activity by the staining for von Willebrand factor (vWF) and CD31 in oral pyogenic granulomas and hemangiomas. The results showed that there was no statistically significant difference in the angiogenesis index between the lesions evaluated. The average microvessel density determined for MVC (microvessel count) using CD31 was 60.64 for hemangiomas and 59.64 for pyogenic granulomas, while angiogenic index determined using vWF was 64.24 and 62.20 in these lesions. The results showed that the cells highlighted by staining for vWF were more uniform than in those stained for CD31. There was no statistically significant difference between the lesions for the number of cells highlighted by staining for VEGF-C1. However, the mean number of cells highlighted in pyogenic granuloma specimens was higher (153.23) when compared to oral hemangioma specimens (115.17). The VEGF-positive cells were endothelial cells and fibroblasts in hemangiomas and macrophages and fibroblasts in pyogenic granulomas. These results effort the role of the angiogenic factors in the etiopathogenesis of the hemangiomas and pyogenic granulomas, however, it showed that microvessel quantification is not useful in the differential diagnosis of these lesions.


Subject(s)
Biomarkers/analysis , Granuloma, Pyogenic/pathology , Hemangioma/blood supply , Mouth Neoplasms/blood supply , Neovascularization, Pathologic/metabolism , Diagnosis, Differential , Endothelial Cells/metabolism , Fibroblasts/metabolism , Hemangioma/pathology , Humans , Immunohistochemistry , Macrophages/metabolism , Mouth Neoplasms/pathology , Platelet Endothelial Cell Adhesion Molecule-1/biosynthesis , Vascular Endothelial Growth Factor C/biosynthesis , von Willebrand Factor/biosynthesis
5.
Pathology ; 36(4): 316-20, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15370129

ABSTRACT

AIMS: To determine the origin of mono-, bi- and multinucleate stellate giant cells in giant cell fibroma, fibrous hyperplasia and fibroepithelial polyp of the oral mucosa. METHODS: Ten cases of each lesion were studied immunohistochemically using anti-vimentin, -HHF-35, -CD68 and -factor XIIIa antibodies. Immunoreactivity of the cells was determined in the papillary and reticular lamina propria of these lesions. RESULTS: Vimentin positivity in both the papillary and reticular lamina propria was observed for most samples, especially giant cell fibroma cases. CONCLUSIONS: The immunohistochemical findings of the present study suggest that the mono-, bi- or multinucleate stellate giant cells observed in the lesions studied derived from the fibroblastic lineage.


Subject(s)
Fibroma/metabolism , Giant Cells/metabolism , Mouth Diseases/metabolism , Mouth Mucosa/metabolism , Mouth Mucosa/pathology , Polyps/metabolism , Actins/metabolism , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Cell Lineage , Factor XIIIa/metabolism , Fibroblasts/cytology , Fibroma/pathology , Giant Cells/cytology , Giant Cells/pathology , Humans , Immunohistochemistry , Mouth Diseases/pathology , Polyps/pathology , Vimentin/metabolism
6.
Int J Exp Pathol ; 84(6): 259-65, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14748745

ABSTRACT

An immunohistochemical analysis of 32 cases of oral squamous cell carcinoma (eight in the inferior lip, eight in the lateral angle of the tongue, eight in the palate and eight in the mouth floor) was performed to evaluate the expression pattern of c-erbB-2 protein and S-100-positive cells in the lesions. The immunohistochemical expression was correlated with the tumour anatomical site and histological grading of malignancy. A higher frequency of c-erbB-2-positive cases was found in the tongue, even though no correlation could be detected between the protein expression and the tumour histological grading. With respect to the S-100-positive cells, it was observed that a quantitative decrease was present in the cases classified as high-grade tumours when compared to the low ones (P = 0.0007). Thus, c-erbB-2 immunohistochemical expression is correlated with anatomical localization, and the expression of the S-100 Langerhans' cell markers is decreased significantly in high-grade carcinomas.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/metabolism , Mouth Neoplasms/metabolism , Receptor, ErbB-2/metabolism , S100 Proteins/metabolism , Carcinoma, Squamous Cell/pathology , Humans , Mouth Neoplasms/pathology , Neoplasm Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL